People Roland Brock

Contact

Roland Brock PhD

+31 (0)24 366 62 13
contact

Roland Brock full professor

With his research group, Roland Brock aims at the development of new drug delivery strategies for oligonucleotides, peptides and proteins.

read more

Roland Brock full professor

Research in our group aims at the development of new drug delivery strategies for oligonucleotides, peptides and proteins. In particular, we are interested in the mechanisms by which so-called cell-penetrating peptides (CPP) enter cells and in the application of these peptides for drug delivery.

Cellular drug delivery is a two-sided relationship of the drug delivery vector and the capacity of the cell to respond to this vector and induce uptake without toxicity. Therefore, we combine research on the design of CPP and carriers for oligonucleotide delivery with research on the biochemical details of the interaction of these carriers with cells, and the cellular signal transduction mechanisms that are involved in uptake.

This research uses a broad spectrum of techniques ranging from the physicochemical characterization of oligonucleotide complexes to high-resolution confocal microscopy and animal experiments. 

Roland Brock holds the chair of Biochemistry of Integrated Systems in the department of Biochemistry. Since 2007 he is also head of the Department of Biochemistry. In addition to pursuing interests in basic science, his group has been involved in numerous collaborations with biotech companies and the pharmaceutical industry.

Personal prizes & awards national & international

  • Funding of an independent young research group by the Volkswagen Foundation (2002 – 2009)

Additional functions

  • Associate Editor, European Journal of Pharmaceutics and Biopharmaceutics (2015 – present)

Social media


Field of study

Biochemistry

Research group Targeted nanomedicines

Roland Brock’s group focuses on the targeted delivery of molecules such as oligonucleotides, toxins and photosensitizers to modulate cell function and/or induce cell death. This research involves fundamental studies of formulation strategies and uptake mechanisms as well as preclinical applications.

read more

Radboud Institute for Molecular Life Sciences

Our main aim is to achieve a greater understanding of the molecular mechanisms of disease. By integrating fundamental and clinical research, we obtain multifaceted knowledge of (patho)physiological processes. read more